Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 463
Gene Symbol: ZFHX3
ZFHX3
0.010 Biomarker phenotype BEFREE The effect of miRNAs on ZFHX3-dependent atrial arrhythmia was evaluated through in vitro and in vivo assays in mice. 31152485 2019
Entrez Id: 55906
Gene Symbol: ZC4H2
ZC4H2
0.010 GeneticVariation phenotype BEFREE ECMO is probably the MCS of choice in cardiogenic shock with; biventricular failure, respiratory failure, life-threatening arrhythmias and cardiac arrest. 30116917 2018
Entrez Id: 7535
Gene Symbol: ZAP70
ZAP70
0.010 Biomarker phenotype BEFREE The ECG in 8 of the 10 control cases was read as AF by at least 80% percent of observers even though the EGMs from the Constellation showed organized activation and consistent DF (STD of DF < 0.001) in all the electrodes confirming the arrhythmia as AFL in 10/10 cases. 30029778 2019
Entrez Id: 129446
Gene Symbol: XIRP2
XIRP2
0.010 Biomarker phenotype BEFREE Prehypertrophic upregulation of Xirp2 in cMyBP-C<sup>-/-</sup> hearts supports a growing body of evidence suggesting Xirp2 has the capacity to elicit both hypertrophy and arrhythmias in HCM. 30410445 2018
Entrez Id: 26100
Gene Symbol: WIPI2
WIPI2
0.100 Biomarker phenotype HPO
Entrez Id: 7450
Gene Symbol: VWF
VWF
0.020 Biomarker phenotype BEFREE Stepwise multiple regression analyses demonstrated that the arrhythmia duration (approximately 3 years) was an independent predictor of abnormal von Willebrand factor, fibrinogen and soluble P -selectin levels. 15087601 2003
Entrez Id: 7450
Gene Symbol: VWF
VWF
0.020 Biomarker phenotype BEFREE von Willebrand Factor is steadily elevated throughout the course of dysrhythmia in NVAF patients treated with warfarin and in those with higher intensity of left atrium blood stasis. 28952167 2017
Entrez Id: 738
Gene Symbol: VPS51
VPS51
0.010 Biomarker phenotype BEFREE Ang-2 was higher in Fontan patients with active or recent arrhythmia (11,396.0 ± 3,457.7 vs 8,118.2 ± 2,795.1 pg/mL, p < 0.05). 31797976 2019
Entrez Id: 7428
Gene Symbol: VHL
VHL
0.100 Biomarker phenotype HPO
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.010 Biomarker phenotype BEFREE VEGF inhibitors increase risks of hypertension, heart failure, thromboembolism and arrhythmia. 28929822 2018
Entrez Id: 7414
Gene Symbol: VCL
VCL
0.010 Biomarker phenotype BEFREE This study initially shows both physical and functional interaction between VCL and cardiac sodium channel, and suggests an important role for respiratory acidosis in triggering the fatal arrhythmia underlying SUNDS. 28218286 2017
Entrez Id: 57176
Gene Symbol: VARS2
VARS2
0.010 Biomarker phenotype BEFREE Using whole-genome sequencing technique, compound heterozygous mutations of the VARS2 gene were revealed, with one previously unreported frameshift mutation.<b>Conclusion:</b> Our report extends the phenotypic spectrum of VARS2-related disorders with an initial presentation of epileptic encephalopathy and early death due to malignant arrhythmia. 31623496 2019
Entrez Id: 7357
Gene Symbol: UGCG
UGCG
0.010 Biomarker phenotype BEFREE Blood glucose measurements in addition to common vital parameters (GCS, heart rate, blood pressure, breathing frequency) may help identify patients at risk for cardiopulmonary arrest and dysrhythmias. 30005711 2018
Entrez Id: 7351
Gene Symbol: UCP2
UCP2
0.010 Biomarker phenotype BEFREE Through modulation of cardiac Ca<sup>2+</sup> handling, UCP2 affects cardiac electrophysiology and influences the susceptibility for Ca<sup>2+</sup> -mediated arrhythmias. 28370799 2017
Entrez Id: 7306
Gene Symbol: TYRP1
TYRP1
0.010 Biomarker phenotype BEFREE These could include atrial-selective ion channels (e.g. atrial I(Na), I(Kur) and I(K,ACh)), pathology-selective ion channels (constitutively active I(K,ACh), TRP channels), ischemia-uncoupled gap junctions, proteins related to malfunctioning intracellular Ca2+ homeostasis (e.g., "leaky" ryanodine receptors, overactive Na+, Ca2+ exchanger) or risk factors for arrhythmias ("upstream" therapies). 20624425 2010
Entrez Id: 11334
Gene Symbol: TUSC2
TUSC2
0.010 Biomarker phenotype BEFREE This case provides support in favor of a bidirectional relationship between SDB and AF and suggests that data available from PAP machines may be useful in serial assessment of SDB status relative to heart rhythm. 30373693 2018
Entrez Id: 7276
Gene Symbol: TTR
TTR
0.150 GeneticVariation phenotype BEFREE We evaluated the DB test in patients with hereditary transthyretin amyloid (ATTRm) amyloidosis, where autonomic dysregulation and atrial arrhythmias are common. 29394116 2018
Entrez Id: 7276
Gene Symbol: TTR
TTR
0.150 GeneticVariation phenotype BEFREE Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR Val30Met) patients. 15257048 2004
Entrez Id: 7276
Gene Symbol: TTR
TTR
0.150 Biomarker phenotype BEFREE TTR-mediated amyloid cardiomyopathies are chronic and progressive conditions that lead to arrhythmias, biventricular heart failure, and death. 23716704 2013
Entrez Id: 7276
Gene Symbol: TTR
TTR
0.150 GeneticVariation phenotype BEFREE Continuous development of arrhythmia is observed in Swedish transplant patients with familial amyloidotic polyneuropathy (amyloidogenic transthyretin Val30Met variant). 21280184 2011
Entrez Id: 7276
Gene Symbol: TTR
TTR
0.150 Biomarker phenotype HPO
Entrez Id: 7276
Gene Symbol: TTR
TTR
0.150 GeneticVariation phenotype BEFREE Wild-type ATTR amyloidosis (ATTR-wt) is characterized by the accumulation of amyloid in the heart, leading to fatal heart failure and arrhythmia. 31731233 2019
Entrez Id: 7274
Gene Symbol: TTPA
TTPA
0.100 Biomarker phenotype HPO
Entrez Id: 7273
Gene Symbol: TTN
TTN
0.120 Biomarker phenotype BEFREE Aberrant TTN splicing is thought to be the main determinant of RBM20-induced dilated cardiomyopathy, but is not likely to explain the increased risk of arrhythmias. 29650543 2018
Entrez Id: 7273
Gene Symbol: TTN
TTN
0.120 Biomarker phenotype HPO